[1] |
ZHANG Li-jie*, HAN Xi-qin, WANG Jing-ping, CHEN Yu-hui, CHEN Sheng-yu, CHEN Ling, LI Bo, LIN Ming-gui, LI You-lun, SHI Lian, XI Xiu-e, MA Li-ping, WANG Xin, WANG Fei, ZHAO Cai-yan, WANG Fu-rong, CHEN Sen-lin, WU Xiang, LI Po, ZHANG Peng, LENG Xue-yan, ZHANG Hai-qing, CAO Wen-li, SHU Wei, SUN Yu-xian, XIE Shi-heng, TIAN Xi-zhong, HUANG Xue-rui, DU Jian, GAO Wei-wei.
The relationship between bacterial load and treatment failure and recurrence of sputum positive retreatment pulmonary tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2021, 43(4): 335-340.
|
[2] |
LIANG Rui-yun, FANG Wei-jun, REN Hui-li, LI Hui-ru, ZHANG Hui, LI Cheng-cheng.
Analysis of CT features of drug-resistant pulmonary tuberculosis with cavity
[J]. Chinese Journal of Antituberculosis, 2021, 43(4): 341-345.
|
[3] |
LIU Ting*, WANG Liang, YANG Mei.
The study on the anti-tuberculosis activity of polymorphonuclear cell from peripheral blood of patients with multidrug-resistant pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2021, 43(4): 352-356.
|
[4] |
ZHANG Chen-chen*, TAN Wei-guo, GUO Hui-xin, HUANG Xin-chun, CHEN Yan-mei, WEI Wen-jing.
The effect of Mycobacterium tuberculosis infection on sputum flora structure
[J]. Chinese Journal of Antituberculosis, 2021, 43(4): 357-363.
|
[5] |
HE Yi-jun, ZHANG Hao-ran, XIN He-nan, GAO Lei.
Optimizing the application of tuberculin skin test
[J]. Chinese Journal of Antituberculosis, 2021, 43(3): 204-210.
|
[6] |
CHENG Jun, ZHANG Can-you, CHEN Hui, ZHANG Hui, ZHAO Yan-lin.
Strengthen tuberculosis control strategy in key populations according to local conditions
[J]. Chinese Journal of Antituberculosis, 2021, 43(3): 217-221.
|
[7] |
WANG Xi-jiang, TAN Yun-hong, HE Wen-cong, OU Xi-chao, LIU Dong-xin, ZHAO Yan-lin.
The correlation between rifampicin and isoniazid resistance-related gene mutations and resistance level in Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2021, 43(3): 248-254.
|
[8] |
DUAN Hui-juan, CHU Hong-qian, KONG Cheng-cheng, DAI Guang-ming, CAO Ting-ming, SUN Zhao-gang.
Evaluation of the effect of skin reaction on 11 Mycobacterium tuberculosis antigens
[J]. Chinese Journal of Antituberculosis, 2021, 43(3): 255-260.
|
[9] |
ZHANG Chun-xia, XU Gui-sheng, SHI Jin-yan.
Research progress on diagnostic methods of multidrug-resistant tuberculosis
[J]. Chinese Journal of Antituberculosis, 2021, 43(3): 291-294.
|
[10] |
KUANG Hao-bin, XIE Yu-hong, FENG Zhi-yu, QIN Hong-juan, LIAO Ya-yi, WANG Min, ZHANG Hong, YUANG Yuan, WU Di, CHEN Ze-ying, TAN Shou-yong.
Analysis on the effect of management strategies for multidrug-resistant tuberculosis in Guangzhou from 2014-2019
[J]. Chinese Journal of Antituberculosis, 2021, 43(2): 113-118.
|
[11] |
WANG Pei, ZHAO Guo-lian, LEI Qian, ZHENG Dan, CUI Xiao-li, ZHOU Jun.
Comparison of the clinical application between fluorescence PCR probe melting curve and Micropore-plate method in determining the drug resistance of Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2021, 43(2): 132-138.
|
[12] |
LI Yuan-chun, ZHANG Yue, ZENG Xiang-jie, HE Wen-cong, QIU Qian, ZHAO Yan-lin, LI Yan-ming.
Subspecies and in vitro drug sensitivity analysis of Mycobacterium intracellular clinical isolates
[J]. Chinese Journal of Antituberculosis, 2021, 43(2): 147-152.
|
[13] |
WANG Xiu-jun, LIU Qiu-yue, CHEN Xiao-feng, YU Lei, MA Yan, HAN Fen.
Study on plasma proteomics of patients with secondary pulmonary tuberculosis based on label-free quantitative technology
[J]. Chinese Journal of Antituberculosis, 2021, 43(2): 159-165.
|
[14] |
GUO Qian, SHEN Chen, SHEN A-dong.
Research progress of stem cells in Mycobacterium tuberculosis infection
[J]. Chinese Journal of Antituberculosis, 2021, 43(2): 186-189.
|
[15] |
HU Wei-hua, JIN Long, CHU Nai-hui.
Analysis of drug resistance characteristics of MDR/XDR-TB patients complicated with type 2 diabetes mellitus
[J]. Chinese Journal of Antituberculosis, 2021, 43(1): 26-30.
|